期刊文献+

米力农治疗心衰26例的疗效观察 被引量:7

下载PDF
导出
摘要 目的:观察米力农注射液治疗难治性心衰患者的疗效观察。方法:采用单盲对照法分为治疗组26例及对照组20例。治疗组用米力农注射液2支加入生理盐水500ml中静滴,1次/日,7天1个疗程,原用药不变。对照组除未用米力农外,其余治疗同治疗组。结果:对照组治疗7天后LVEF,6分钟步行距离均有所增加,LVDd有所减小,但差异均无显著意义(P>0.05);治疗组治疗后上述指标明显改善(P<0.05),两组比较,治疗组LVEF、6分钟步行距离明显增加,LVDd明显缩小,两组疗效比较差异有显著性(P<0.05)。结论:米力农治疗难治性心衰疗效显著,并无不良反应。
作者 石丰富
出处 《中国社区医师(医学专业)》 2012年第24期23-23,共1页
  • 相关文献

参考文献3

二级参考文献13

  • 1闫子星,马捷.小剂量单次静脉注射米力农对兔顿抑心肌血清cTnI的影响[J].中国医师杂志,2005,7(10):1307-1308. 被引量:9
  • 2王凤,王继征,于平,冯磊,张国清.米力农联合单硝酸异山梨酯治疗重度充血性心衰近期疗效观察[J].山东医药,2006,46(19):56-57. 被引量:10
  • 3马洪林.米力农在慢性肺心病心力衰竭治疗中的作用[J].临床荟萃,2006,21(16):1197-1198. 被引量:10
  • 4Honerjager P. pharmacology of bipyridine phosphodi- esterase Ⅲ inhibitors [J]. Am Heart J, 1991, 121 (6pt2):1 939-1 944.
  • 5Yamaura K,Okamoto H,Akiyoshi K,et al. Effect of low. dose milrinone on gastri intramueosal pH and systemic inflammation after hypothermic cardiopulmonary bypass[J]. J Cardiothorae Vase Anesh ,2001, 15(2) :197-203.
  • 6Sulek C A,Blas M L,I.obato E B. Milrinone increase milddle cerebral artery blood flow velocity after car- diopulmonary bypass [ J ]. J Cardiothorac Vasc Anesth, 2002,16 ( 1 ) : 64-69.
  • 7Mounoff T,Loiek H M ,VanAken H,et al. Milrinone modnlates endoto xemia systemic inflammation and subsequent alate phase response after cardiopulmonary bypass (CPB) [J]. Anesthesiology, 1999,90 (1) :72-80.
  • 8Cusik D A,Pfeifer P B,Leuigg R J. Effects of in travenons milrinone followed by titration of gigh-chose and vasodilator therapy on clinical outcome and rehospitalization rates in patients with severe heart failare[J]. Am J Cardiol,1998,82(9):1 060-1 065.
  • 9Hatziacharias A, Makris T, Krespi P,et al. Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure [J]. Am Heart J,1999,138(2Pt1):241-246.
  • 10徐兵,唐丽萍,张浩,陶凌,李泽浦.影响心衰患者再入院的多因素分析[J].中国心血管病研究,2008,6(3):205-208. 被引量:16

共引文献34

同被引文献35

  • 1Lakshminrusimha S,Porta NF, Farrow KN,et al.Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent ptdmonary hypertension of the newborn [J].Pediatr Crit Care Med,2009,10(1): 106-112.
  • 2国家药典委员会.WSl-(X-109)-2006Z米力农[S].2006.
  • 3Chihoho B, Sage AB, Smolenski RT, et al. A clinical assay for the measurement of milrinone in plasma by HPLC mass spectrometry [ J ]. Biomed Chromatogr,2012,26 ( 5 ) :566 - 570.
  • 4陆再英,钟南山.心力衰竭内科学[M].北京:人民卫生出版社,2012:165.
  • 5Watanable H, Kajimoto K, Kawana M. Combination therapy with PDE III inhibitor for heart failure [ J ]. Nihon Rinsho, 2011,65 (Suppl 5 ) : 134-139.
  • 6Shibata I, Cho S, Yoshitomi O, et al. milrinone and levosimendan ad- ministered after reperfusion improve myocardial stuning in swie [ J ]. Scand Cardiovase J,2013,47( 1 ) :50-57.
  • 7Lakshminrusimha S, Porta NF, Farrow KN, et al. Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistentpulmonary hypertension of the newborn [ J ]. Pediatr CritCare Med ,2011,10 ( 1 ) : 106-112.
  • 8Savarese G, Trimareo B, Dellegrottaglie S, et al. Natfiuretic peptide guided therapy inchronic heart failure : a meta-analysis of 2,686 pa- tients in 12 randomized trials [ J ]. PLoS One, 2014,9 ( 4 ) : e96706.
  • 9秋爽,殷显德,刘晓燕,陈炜.米力农注射液治疗充血性心衰临床观察[J].山东医药,2009,49(37):96-97. 被引量:4
  • 10邱五一.米力农治疗难治性心衰疗效观察[J].安徽医药,2010,14(8):965-965. 被引量:5

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部